| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 |
| filingDate |
1989-12-11^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1991-02-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24409c701473d071ab4d3ca384a2d2d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b1fa2e864f5f3894856b47dab93e60 |
| publicationDate |
1991-02-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4992450-A |
| titleOfInvention |
Piperidine opioid antagonists |
| abstract |
This invention provides trans-3,4 1-substituted-3-substituted-4-methyl-4-(3-substituted phenyl)piperidines as opioid antagonists capable of blocking the mu or kappa receptors in the brain. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7696220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5859043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5159081-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011071163-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5270328-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011065743-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5136040-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5498718-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6469030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6468971-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5250542-A |
| priorityDate |
1987-04-16^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |